The BRAF gene plays a significant role in regulating cell growth, and mutations in this gene are linked to various cancers, including melanoma, colorectal cancer, and non-small cell lung cancer (NSCLC). Targeting the BRAF mutation with specific inhibitors has revolutionized the treatment o